These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36514874)

  • 1. Therapeutic effects and the impact of statins in the prevention of ulcerative colitis in preclinical models: A systematic review.
    Vital KD; Cardoso BG; Lima IP; Campos AB; Teixeira BF; Pires LO; Dias BC; de Alcantara Candido P; Cardoso VN; Fernandes SOA
    Fundam Clin Pharmacol; 2023 Jun; 37(3):493-507. PubMed ID: 36514874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins in the chemoprevention of colorectal cancer in established animal models of sporadic and colitis-associated cancer.
    Pikoulis E; Margonis GA; Angelou A; Zografos GC; Antoniou E
    Eur J Cancer Prev; 2016 Mar; 25(2):102-8. PubMed ID: 25768976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and inflammatory bowel disease: Where do we stand?
    Peppas S; Piovani D; Peyrin-Biroulet L; Danese S; Bonovas S
    Eur J Intern Med; 2020 May; 75():10-14. PubMed ID: 32151491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes.
    Lean QY; Gueven N; Eri RD; Bhatia R; Sohal SS; Stewart N; Peterson GM; Patel RP
    Expert Rev Clin Pharmacol; 2015; 8(6):795-811. PubMed ID: 26308504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferons for induction of remission in ulcerative colitis.
    Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ulcerative Effect of Curcumin-Galactomannoside Complex on Acetic Acid-Induced Experimental Model by Inhibiting Inflammation and Oxidative Stress.
    Sheethal S; Ratheesh M; Jose SP; Asha S; Krishnakumar IM; Sandya S; Girishkumar B; Grace J
    Inflammation; 2020 Aug; 43(4):1411-1422. PubMed ID: 32240451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats.
    Maheshwari RA; Balaraman R; Sailor GU; Sen DB
    Indian J Pharmacol; 2015; 47(1):17-21. PubMed ID: 25821305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK; Wang JJ
    Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
    J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of sarsasapogenin in TNBS induced ulcerative colitis in rats associated with downregulation of pro-inflammatory mediators and oxidative stress.
    Mandlik DS; Mandlik SK; Patel S
    Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):571-583. PubMed ID: 34338577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferons for induction of remission in ulcerative colitis.
    Wang Y; MacDonald JK; Benchimol EI; Griffiths AM; Steinhart AH; Panaccione R; Seow CH
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006790. PubMed ID: 26368001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of statins in autoimmune disease therapy.
    Marai I; Shoenfeld Y
    Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells: Possible mediators for the anti-inflammatory action of statins.
    Shahbaz SK; Sadeghi M; Koushki K; Penson PE; Sahebkar A
    Pharmacol Res; 2019 Nov; 149():104469. PubMed ID: 31577918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effect of D-Carvone against Dextran Sulfate Sodium Induced Ulcerative Colitis in Balb/c Mice and LPS Induced RAW Cells via the Inhibition of COX-2 and TNF-α.
    Zhu X; Wang G; Wu S; Li C
    J Environ Pathol Toxicol Oncol; 2020; 39(3):235-245. PubMed ID: 32865915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis.
    Goulart RA; Barbalho SM; Rubira CJ; Araújo AC; Lima VM; Rogerio Leoni B; Guiguer EL
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1171-1179. PubMed ID: 32772752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.